Lactulose Dosing
For constipation, start with 15-30 mL (10-20 g) daily and titrate up to 60 mL (40 g) daily if needed; for hepatic encephalopathy, use 30-45 mL (20-30 g) three to four times daily, titrated to produce 2-3 soft stools per day. 1
Constipation Dosing
The FDA-approved dosing for chronic idiopathic constipation begins at 10-20 g (15-30 mL or 1-2 packets) daily, with escalation permitted to 40 g (60 mL or 2-4 packets) daily as needed 2. This approach is supported by the 2023 AGA-ACG guidelines, though they note the evidence quality is very low, based on two small RCTs from over 40 years ago 2.
Key implementation points:
- Start low and titrate based on response
- Goal is improvement in bowel movement frequency without excessive bloating
- Consider lactulose only after fiber and OTC laxatives have failed
- Bloating and flatulence are dose-dependent and very common, limiting tolerability 2
Common pitfall: The evidence for lactulose in constipation is weak compared to other agents. The 2023 guidelines give stronger recommendations for bisacodyl or sodium picosulfate, which have moderate-quality evidence 2.
Hepatic Encephalopathy Dosing
Acute/Overt HE
For acute overt hepatic encephalopathy, the FDA label specifies 30-45 mL (20-30 g) three or four times daily 1. The 2022 EASL guidelines emphasize titrating to achieve 2-3 soft bowel movements per day 3.
Rapid induction protocol:
- Hourly doses of 30-45 mL may be used initially to induce rapid laxation 1
- Once laxative effect achieved, reduce to standard maintenance dosing
- Improvement may occur within 24 hours but can take 48+ hours 1
For patients unable to take oral medication:
- Mix 300 mL lactulose with 700 mL water or saline as retention enema 1
- Retain for 30-60 minutes
- Repeat every 4-6 hours until patient can take oral medication 1
- Critical warning: Recent 2025 data shows rectal lactulose is strongly associated with hypernatremia (OR=7.12) and remarkably high mortality in HE patients 4. Doses ≥485 g over 5 days significantly increase hypernatremia risk 4. Monitor sodium closely if rectal route is necessary.
Secondary Prophylaxis
Lactulose is strongly recommended as secondary prophylaxis following a first episode of overt HE 3. Continue the same dosing regimen (titrated to 2-3 soft stools daily) for long-term maintenance to prevent recurrence 1.
Add rifaximin if patient experiences >1 additional episode within 6 months of the first 3.
Prevention in GI Bleeding
For patients with variceal bleeding, lactulose via nasogastric tube or enemas is recommended for rapid blood removal to prevent HE 3. A 2011 RCT demonstrated lactulose reduced HE development from 40% to 14% (P=0.03) in acute variceal bleed patients 5.
Special Populations
Pediatric dosing (very limited data available):
- Infants: 2.5-10 mL daily in divided doses 1
- Older children/adolescents: 40-90 mL total daily dose 1
- Reduce immediately if diarrhea occurs; discontinue if it persists 1
Monitoring and Adjustment
- Primary goal: 2-3 soft stools daily for HE; improved bowel frequency for constipation
- Watch for: Dose-dependent bloating, flatulence, diarrhea, and electrolyte disturbances
- Hypernatremia risk: Particularly with high-dose or rectal lactulose in HE patients—monitor sodium levels closely 4
- Consider discontinuation in HE patients with improved liver function, controlled precipitants, and stable nutritional status (individualized basis) 3